Caliway Biopharmaceuticals Co., Ltd.

TWSE:6919 Stock Report

Market Cap: NT$71.2b

Caliway Biopharmaceuticals Ownership

Who are the major shareholders and have insiders been buying or selling?


Recent Insider Transactions

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.


Ownership Breakdown

What is the ownership structure of 6919?
Owner TypeNumber of SharesOwnership Percentage
Institutions46,5140.0334%
Public Companies4,800,0123.44%
Individual Insiders38,380,30427.5%
General Public96,191,95669%

Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 13.3%.


Top Shareholders

Top 9 shareholders own 31.01% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
11.1%
Yufang Ling
15,526,726NT$7.9b0.71%no data
7.93%
Kuihui Xu
11,051,498NT$5.6b1.01%no data
6.25%
Gaorong Zhang
8,712,020NT$4.5b0%no data
3.44%
Orient EuroPharma Co., Ltd.
4,800,012NT$2.5b0%no data
2.21%
Quan-Cheng Qiu
3,076,060NT$1.6b0%no data
0.028%
Exchange Traded Concepts, LLC
38,563NT$19.7m0%0.01%
0.01%
Zhao-Jing Yuan
14,000NT$7.2m0%no data
0.0056%
Eaton Vance Management
7,877NT$4.0m0%no data
0.00005%
State Street Global Advisors, Inc.
74NT$35.6k-99.9%no data